IL-6, IL-12, IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients

计划入组 80 人 · 首次发布于 2024 年 8 月 16 日

SC IL-1Ra in SAH - Phase III Trial (SCIL)

计划入组 612 人 · 首次发布于 2017 年 8 月 15 日

Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects

计划入组 34 人 · 首次发布于 2017 年 12 月 26 日

Nemolizumab(Nemluvio, Mitchga)

xB3-IL-1RA

IL-25

Simcha Il 18, Inc.

United States

Alliance Foundation Trials, LLC

United States

UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA

Italy

Chugai's Nemolizumab Research Honored with 11th JBDA Award for Drug Discovery

Sunshine Guojian Posts 95% Profit Surge as Two Autoimmune Antibodies Win NMPA Approval

Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones